These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4148514)

  • 1. Letter: Preliminary investigation of the metabolism of piribedil (ET 495); a new central dopaminergic agonist and potential anti-parkinson agent.
    Jenner P; Taylor AR; Campbell DB
    J Pharm Pharmacol; 1973 Sep; 25(9):749-50. PubMed ID: 4148514
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Effects of piribedil (ET 495)--a dopaminergic receptor stimulating agent in Parkinson's disease.
    Lieberman A; Le Brun Y; Zolfaghari M
    Psychopharmacol Bull; 1974 Jul; 10(3):42-3. PubMed ID: 4419369
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid structure elucidation of drug metabolites by use of stable isotopes.
    Prox A; Zimmer A; Machleidt H
    Xenobiotica; 1973 Feb; 3(2):103-12. PubMed ID: 4716639
    [No Abstract]   [Full Text] [Related]  

  • 4. Disposition of the psychotropic drugs buspirone, MJ-13805 and piribedil, and of their common active metabolite 1-(2-pyrimidinyl)-piperazine in the rat.
    Caccia S; Fong MH; Guiso G
    Xenobiotica; 1985 Oct; 15(10):835-44. PubMed ID: 2866634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of dopaminergic receptor stimulating agent (Pribedil, ET 495) in Parkinson's disease.
    Lieberman A; Le Brun Y; Boal D; Zolfaghari M
    Adv Biochem Psychopharmacol; 1974; 12(0):415-25. PubMed ID: 4425258
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative effects of apomorphine, piribedil and other neurotropic agents on central analgesic-induced catatonia in the rat.
    Poignant JC; Gressier H; Malecot E
    Eur J Pharmacol; 1974 Nov; 29(1):195-9. PubMed ID: 4154859
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine receptor binding activity of anti-parkinsonian active piperazino derivatives.
    Srivastava VK; Palit G; Agarwal AK; Shanker K
    Indian J Exp Biol; 1988 Jan; 26(1):15-7. PubMed ID: 3403004
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of piribedil in biological materials by gas-liquid chromatography-mass fragmentography.
    Fanelli R; Frigerio A
    J Chromatogr; 1974 Jun; 93(2):441-6. PubMed ID: 4844345
    [No Abstract]   [Full Text] [Related]  

  • 9. Simultaneous labelling with stable and radioactive isotopes in drug metabolism studies.
    Zimmer A; Prox A; Pelzer H; Hankwitz R
    Biochem Pharmacol; 1973 Sep; 22(18):2213-22. PubMed ID: 4733676
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Clinical studies of dopaminergic mechanisms.
    Chase TN
    Psychopharmacol Bull; 1974 Jul; 10(3):43-4. PubMed ID: 4419336
    [No Abstract]   [Full Text] [Related]  

  • 11. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M; Dekeyne A; Papp M; Millan MJ
    Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and quantitation of 1-(2-pyrimidinyl)piperazine, an active metabolite of the anxiolytic agent buspirone, in rat plasma and brain.
    Caccia S; Garattini S; Mancinelli A; Muglia M
    J Chromatogr; 1982 Dec; 252():310-4. PubMed ID: 7182413
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacobiochemistry of the coronary agent N,N'-bis(3-(3',4',5'-trimethoxy-benzoyloxy)-propyl)-homopiperazine(dihydrochloride-monohydrate)].
    Schriewer H; Rauen HM
    Arzneimittelforschung; 1972 Sep; 22(9):1455-9. PubMed ID: 4678606
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on metabolism of trazodone. I. Metabolic fate of (14C)trazodone hydrochloride in rats.
    Yamato C; Takahashi T; Fujita T
    Xenobiotica; 1974 May; 4(5):313-26. PubMed ID: 4407065
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic fate of 6,6,9-trimethyl-9-azabicyclo(3,3,1)non-3 -yl , -di(2-thienyl)glycolate hydrochloride monohydrate (PG-501).
    Meshi T; Nakamura S; Sato Y
    Chem Pharm Bull (Tokyo); 1972 Aug; 20(8):1687-98. PubMed ID: 4639305
    [No Abstract]   [Full Text] [Related]  

  • 16. Piribedil, a dopamine agonist, in Parkinson's disease.
    Sweet RD; Wasterlain CG; McDowell FH
    Clin Pharmacol Ther; 1974 Dec; 16(6):1077-82. PubMed ID: 4611465
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of piribedil and one of its metabolites on the concentration of homovanillic acid in the rat brain.
    Jori A; Cecchetti G; Dolfini E; Monti E; Garattini S
    Eur J Pharmacol; 1974 Jul; 27(2):245-8. PubMed ID: 4851685
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on analgesic agents. 13. Metabolic fate of 1-butyrl-4-cinnamylipiperazine hydrochloride(BCP-HCl) in rats.
    Terayama H; Naruke T; Kasai S; Numata M; Nakayama H
    Chem Pharm Bull (Tokyo); 1973 Jan; 21(1):12-20. PubMed ID: 4711509
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute hypotensive effect of a central dopaminergic agonist, piribedil, administered intravenously in the normotensive human].
    Ziegler M; Georgiadis G; Elghozi JL
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1186-90. PubMed ID: 6441537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood level courses, thin layer chromatographic separation and metabolism of 1,3-dioxolanes and 1,3-oxathiolanes in the rat].
    Köster D; Bekemeier H; Schmollack W
    Pharmazie; 1975 Mar; 30(3):172-4. PubMed ID: 1153472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.